Page last updated: 2024-11-02

pentamidine and Community Acquired Infection

pentamidine has been researched along with Community Acquired Infection in 2 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Research Excerpts

ExcerptRelevanceReference
"Pneumonia is an important cause of morbidity and mortality in the United States."2.39Prevention of community-acquired and nosocomial pneumonia. ( Santos, MR; Simberkoff, MS, 1996)
"Bacteremia was caused by Staphylococcus aureus (23%), Pseudomonas aeruginosa (18%), Escherichia coli (16%), Streptococcus pneumoniae (14%) and others (31%)."1.29Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. ( Edge, MD; Rimland, D, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edge, MD1
Rimland, D1
Simberkoff, MS1
Santos, MR1

Reviews

1 review available for pentamidine and Community Acquired Infection

ArticleYear
Prevention of community-acquired and nosocomial pneumonia.
    Current opinion in pulmonary medicine, 1996, Volume: 2, Issue:3

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Vaccines; Community-Acquired Infections; Cross I

1996

Other Studies

1 other study available for pentamidine and Community Acquired Infection

ArticleYear
Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole.
    AIDS (London, England), 1996, Volume: 10, Issue:14

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Community-Acquired

1996